Disease-Specific Derangement of Circulating Endocannabinoids and
Adult
Aged
Aged, 80 and over
Amides
/ blood
Arachidonic Acids
/ blood
Chromatography, Liquid
/ methods
Endocannabinoids
/ blood
Ethanolamines
/ blood
Female
Glycerides
/ blood
Humans
Janus Kinase 2
/ genetics
Male
Middle Aged
Mutation, Missense
Myeloproliferative Disorders
/ blood
Oleic Acids
/ blood
Palmitic Acids
/ blood
Polycythemia Vera
/ blood
Polyunsaturated Alkamides
/ blood
Primary Myelofibrosis
/ blood
Tandem Mass Spectrometry
/ methods
Thrombocythemia, Essential
/ blood
N-acylethanolamines
endocannabinoids
essential thrombocythemia
myelofibrosis
myeloproliferative neoplasms
polycythemia vera
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
11 May 2020
11 May 2020
Historique:
received:
10
04
2020
revised:
06
05
2020
accepted:
09
05
2020
entrez:
15
5
2020
pubmed:
15
5
2020
medline:
23
2
2021
Statut:
epublish
Résumé
Growing evidence highlights the endocannabinoid (EC) system involvement in cancer progression. Lipid mediators of this system are secreted by hematopoietic cells, including the ECs 2-arachidonoyl-glycerol (2AG) and arachidonoyl-ethanolamide (AEA), the 2AG metabolite 1AG, and members of N-acylethanolamine (NAE) family-palmitoyl-ethanolamide (PEA) and oleoyl-ethanolamide (OEA). However, the relevance of the EC system in myeloproliferative neoplasms (MPN) was never investigated. We explored the EC plasma profile in 55 MPN patients, including myelofibrosis (MF;
Identifiants
pubmed: 32403407
pii: ijms21093399
doi: 10.3390/ijms21093399
pmc: PMC7246996
pii:
doi:
Substances chimiques
Amides
0
Arachidonic Acids
0
Endocannabinoids
0
Ethanolamines
0
Glycerides
0
N-acylethanolamines
0
Oleic Acids
0
Palmitic Acids
0
Polyunsaturated Alkamides
0
oleoylethanolamide
1HI5J9N8E6
palmidrol
6R8T1UDM3V
glyceryl 2-arachidonate
8D239QDW64
JAK2 protein, human
EC 2.7.10.2
Janus Kinase 2
EC 2.7.10.2
anandamide
UR5G69TJKH
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : 20930
Organisme : SIE-Società Italiana di Ematologia- e Associazione "Amici di Beat Leukemia Dr. Alessandro Cevenini ONLUS
ID : /
Références
Curr Med Chem. 2010;17(14):1382-93
pubmed: 20166926
Exp Hematol. 2018 Jan;57:30-41.e1
pubmed: 29030083
Blood. 2004 Jul 15;104(2):526-34
pubmed: 15039279
Blood Cancer J. 2018 Sep 21;8(10):89
pubmed: 30291232
FASEB J. 2001 Oct;15(12):2171-8
pubmed: 11641243
Neuropsychopharmacology. 2018 Jan;43(1):155-172
pubmed: 28653665
Oncotarget. 2016 Jul 12;7(28):43974-43988
pubmed: 27304059
Cell Mol Life Sci. 2015 Sep;72(17):3235-52
pubmed: 25957591
Diabetes. 2006 Nov;55(11):3053-60
pubmed: 17065342
Cell Mol Life Sci. 2010 Feb;67(4):601-10
pubmed: 19936621
Mediterr J Hematol Infect Dis. 2018 Nov 01;10(1):e2018068
pubmed: 30416700
J Leukoc Biol. 2015 Jun;97(6):1049-70
pubmed: 25877930
Immunology. 2015 Mar;144(3):352-364
pubmed: 25585882
Mol Metab. 2017 Mar 21;6(5):406-415
pubmed: 28462075
Int J Cancer. 2017 Feb 1;140(3):674-685
pubmed: 27778331
Front Pharmacol. 2019 Apr 05;10:339
pubmed: 31024307
Inflamm Regen. 2018 Oct 1;38:28
pubmed: 30288203
Cell Cycle. 2014;13(24):3938-47
pubmed: 25427281
Ann N Y Acad Sci. 2003 May;996:10-6
pubmed: 12799277
Cancer. 2020 Mar 15;126(6):1243-1252
pubmed: 31860137
J Lipid Res. 2012 Mar;53(3):481-93
pubmed: 22172516
Oncoscience. 2014 Apr 30;1(4):272-282
pubmed: 25594019
Int Rev Neurobiol. 2015;125:1-47
pubmed: 26638763
Blood. 2010 Mar 4;115(9):1703-8
pubmed: 20008785
Biomed Res Int. 2015;2015:839403
pubmed: 26539529
Haematologica. 2017 Jan;102(1):85-93
pubmed: 27540137
Expert Rev Mol Med. 2009 Jan 20;11:e3
pubmed: 19152719
Cell Mol Life Sci. 2016 Dec;73(23):4449-4470
pubmed: 27402121
Mol Metab. 2018 Aug;14:82-94
pubmed: 29935920
Br J Pharmacol. 2015 Jan;172(1):142-58
pubmed: 25205418
J Clin Endocrinol Metab. 2011 Mar;96(3):787-91
pubmed: 21177788
Eur J Pharmacol. 2008 Oct 24;595(1-3):1-6
pubmed: 18778813
Gut. 2014 Aug;63(8):1300-12
pubmed: 24082036
Mediators Inflamm. 2016;2016:5860657
pubmed: 27672242
Prog Lipid Res. 2013 Oct;52(4):633-50
pubmed: 24076098
Anal Biochem. 2013 Mar 15;434(2):275-83
pubmed: 23201387
BMC Cancer. 2016 Jan 16;16:25
pubmed: 26775260
Front Cell Neurosci. 2017 Feb 20;11:39
pubmed: 28265242
Curr Med Chem. 2016;23(22):2350-62
pubmed: 27237820
Oncoimmunology. 2017 Jul 5;6(10):e1345402
pubmed: 29123956
FASEB J. 2017 Feb;31(2):469-481
pubmed: 27623929
Transfusion. 2011 Nov;51 Suppl 4:65S-71S
pubmed: 22074629
FASEB J. 2018 Oct;32(10):5716-5723
pubmed: 29879374
Exp Hematol. 2002 Feb;30(2):142-9
pubmed: 11823049
Mediators Inflamm. 2015;2015:284706
pubmed: 26538823
Br J Pharmacol. 2007 Nov;152(5):671-5
pubmed: 17704826
Neurobiol Stress. 2015;2:44-50
pubmed: 26114153
Blood. 2007 Aug 1;110(3):986-93
pubmed: 17473062
Cancer Cell. 2018 Oct 8;34(4):659-673.e6
pubmed: 30270124
J Clin Oncol. 2011 Feb 10;29(5):573-82
pubmed: 21220604